a year ago
SRPT
AnalystsBiren AminBiren Amin's Stock Forecasts
AnalystsBiren Amin
Analyst Ranking
Bottom 9%
#4761 out of 5184 analysts
Average Return
-2.58%
Win Rate
40%25 out of 63
Risk vs Reward
Poor
Good
Biren Amin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Context Therapeutics IncCNTX | +236.41% | $0.65 | $2.19 | 2025-06-25 - 2026-01-27 | Strong Buy |
Aclaris Therapeutics IncACRS | +143.40% | $1.59 | $3.87 | 2025-07-09 - 2026-01-27 | Strong Buy |
Solid Biosciences IncSLDB | +137.18% | $2.77 | $6.57 | 2025-05-15 - 2026-01-27 | Strong Buy |
Bridgebio Pharma IncBBIO | +103.00% | $38.36 | $77.87 | 2025-04-29 - 2026-01-27 | Strong Buy |
Neurocrine Biosciences IncNBIX | +92.27% | $61.94 | $119.09 | 2017-10-02 - 2018-10-03 | Strong Buy |
Biren Amin Analyst Color
Get additional color on Biren Amin's coverage of popular stocks
Biren Amin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Opus Genetics IncIRD | 1 | Strong Buy | $7.00 | +147.35% | Initiates Coverage On | 2 months ago |
Ascentage Pharma Group InternationalAAPG | 1 | Strong Buy | $48.00 | +87.57% | Initiates Coverage On | 3 months ago |
Sarepta Therapeutics IncSRPT | 12 | Hold | $16.00 | -27.83% | Maintains | 3 months ago |
Bridgebio Pharma IncBBIO | 4 | Strong Buy | $98.00 | +25.85% | Maintains | 3 months ago |
Lenz Therapeutics IncLENZ | 2 | Strong Buy | $67.00 | +245.54% | Maintains | 4 months ago |
Ocular Therapeutix IncOCUL | 2 | Strong Buy | $31.00 | +185.71% | Maintains | 4 months ago |
Monopar TherapeuticsMNPR | 2 | Strong Buy | $95.00 | +35.15% | Maintains | 4 months ago |
Aclaris Therapeutics IncACRS | 1 | Strong Buy | $6.00 | +55.04% | Assumes | 7 months ago |
Context Therapeutics IncCNTX | 1 | Strong Buy | $4.00 | +82.65% | Reiterates | 7 months ago |
Solid Biosciences IncSLDB | 2 | Strong Buy | $17.00 | +158.75% | Maintains | 8 months ago |
Allogene Therapeutics IncALLO | 3 | Strong Buy | $7.00 | +357.52% | Maintains | 8 months ago |
Centessa Pharmaceuticals PLCCNTA | 1 | Strong Buy | $38.00 | +46.21% | Initiates Coverage On | 10 months ago |
Elevation Oncology IncELEV | 2 | Hold | $0.70 | +91.78% | Downgrades | 10 months ago |
Compass Therapeutics IncCMPX | 1 | Strong Buy | $12.00 | +87.21% | Initiates Coverage On | a year ago |
Viking Therapeutics IncVKTX | 2 | Strong Buy | $71.00 | +126.11% | Maintains | a year ago |
Cargo Therapeutics IncCRGX | 3 | Hold | $4.00 | -10.51% | Downgrades | a year ago |
Corbus Pharmaceuticals Holdings IncCRBP | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | a year ago |
Immunome IncIMNM | 3 | Strong Buy | $21.00 | N/A | Maintains | a year ago |
Arcellx IncACLX | 2 | Strong Buy | $115.00 | N/A | Maintains | a year ago |
Apellis Pharmaceuticals IncAPLS | 2 | Hold | $32.00 | N/A | Maintains | a year ago |
Zentalis Pharmaceuticals IncZNTL | 2 | Strong Buy | $70.00 | N/A | Maintains | 3 years ago |
Quince Therapeutics IncQNCX | 2 | Hold | $34.00 | N/A | Downgrades | 5 years ago |
Bioatla IncBCAB | 1 | Strong Buy | $51.00 | N/A | Initiates Coverage On | 5 years ago |
Urovant Sciences LtdUROV | 1 | Hold | $16.25 | N/A | Downgrades | 5 years ago |
Aldeyra Therapeutics IncALDX | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 5 years ago |
Taysha Gene Therapies IncTSHA | 1 | Strong Buy | $34.00 | N/A | Initiates Coverage On | 5 years ago |
Kala Bio IncKALA | 2 | Hold | $500.00 | N/A | Downgrades | 5 years ago |
Immatics NvIMTX | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 6 years ago |
Forma Therapeutics Holdings IncFMTX | 1 | Strong Buy | $54.00 | N/A | Initiates Coverage On | 6 years ago |
Cytomx Therapeutics IncCTMX | 1 | Hold | $10.00 | N/A | Downgrades | 6 years ago |
Calithera Biosciences IncCALA | 1 | Strong Buy | $120.00 | N/A | Initiates Coverage On | 6 years ago |
Regeneron Pharmaceuticals IncREGN | 1 | Strong Buy | $492.00 | N/A | Upgrades | 6 years ago |
Synthorx IncTHOR | 1 | Hold | $68.00 | N/A | Downgrades | 6 years ago |
Ayala Pharmaceuticals IncADXS | 2 | Hold | $2,400.00 | N/A | Downgrades | 8 years ago |
Armo Biosciences IncARMO | 1 | Hold | $50.00 | N/A | Downgrades | 8 years ago |
Bluebird Bio IncBLUE | 4 | Strong Buy | N/A | N/A | Upgrades | 8 years ago |
Anaptysbio IncANAB | 1 | Strong Buy | $101.00 | N/A | Initiates Coverage On | 8 years ago |
Neurocrine Biosciences IncNBIX | 1 | Strong Buy | $69.00 | N/A | Maintains | 8 years ago |
Zynerba Pharmaceuticals IncZYNE | 2 | Hold | N/A | N/A | Downgrades | 8 years ago |
Vertex Pharmaceuticals IncVRTX | 1 | Strong Buy | $155.00 | N/A | Initiates Coverage On | 9 years ago |
Forward Pharma AFWPAY | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Minerva Neurosciences IncNERV | 4 | Strong Buy | $136.00 | N/A | Initiates Coverage On | 9 years ago |
Obseva SaOBSVF | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.